| Estimation of kidney function in oncology: implications for anticancer drug selection and dosing MA Casal, TD Nolin, JH Beumer Clinical Journal of the American Society of Nephrology 14 (4), 587-595, 2019 | 78 | 2019 |
| Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute … MA Casal, SP Ivy, JH Beumer, TD Nolin The Lancet Oncology 22 (9), 1333-1340, 2021 | 39 | 2021 |
| Disruption of SUMO-targeted ubiquitin ligases Slx5–Slx8/RNF4 alters RecQ-like helicase Sgs1/BLM localization in yeast and human cells S Böhm, MJ Mihalevic, MA Casal, KA Bernstein DNA repair 26, 1-14, 2015 | 27 | 2015 |
| CINPA1 binds directly to constitutive androstane receptor and inhibits its activity MT Cherian, SC Chai, WC Wright, A Singh, MA Casal, J Zheng, J Wu, ... Biochemical pharmacology 152, 211-223, 2018 | 23 | 2018 |
| Inclusion of participants with CKD and other kidney-related considerations during clinical drug development: landscape analysis of anticancer agents approved from 2015 to 2019 MA Butrovich, AC Reaves, J Heyward, TJ Moore, GC Alexander, LA Inker, ... Clinical Journal of the American Society of Nephrology 18 (4), 455-464, 2023 | 12 | 2023 |
| Use of physiologically based pharmacokinetic modeling to evaluate the impact of chronic kidney disease on CYP3A4‐mediated metabolism of Saxagliptin MA Butrovich, W Tang, DW Boulton, TD Nolin, P Sharma The Journal of Clinical Pharmacology 62 (8), 1018-1029, 2022 | 8 | 2022 |
| Underrepresentation of black individuals in pivotal trials for novel anticancer drugs: Potential consequence of using estimated creatinine clearance to assess kidney function? MA Butrovich, AC Reaves, J Heyward, TJ Moore, GC Alexander, LA Inker, ... Contemporary Clinical Trials 144, 107631, 2024 | | 2024 |
| Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients MA Butrovich, J Qin, X Xue, SP Ivy, TD Nolin, JH Beumer Cancer Letters 586, 216679, 2024 | | 2024 |
